BioPorto Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Tony Pare
Chief executive officer
DKK 6.3m
Total compensation
| CEO salary percentage | 55.7% |
| CEO tenure | 1.5yrs |
| CEO ownership | n/a |
| Management average tenure | 1.5yrs |
| Board average tenure | 6.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -DKK 75m |
| Dec 31 2022 | DKK 6m | DKK 4m | -DKK 76m |
| Sep 30 2022 | n/a | n/a | -DKK 68m |
| Jun 30 2022 | n/a | n/a | -DKK 62m |
| Mar 31 2022 | n/a | n/a | -DKK 59m |
| Dec 31 2021 | DKK 8m | DKK 374k | -DKK 57m |
Compensation vs Market: Tony's total compensation ($USD913.34K) is above average for companies of similar size in the UK market ($USD348.41K).
Compensation vs Earnings: Tony's compensation has been consistent with company performance over the past year.
CEO
Tony Pare (59 yo)
1.5yrs
Tenure
DKK 6,340,000
Compensation
Mr. Anthony Paul Pare, also known as Tony, serves as Chief Executive Officer of BioPorto A/S since November 2021. He served as Chief Commercial Officer at T2 Biosystems, Inc. since January 08, 2020. He ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.5yrs | DKK 6.34m | no data | |
| Executive VP & CFO | 1.5yrs | DKK 5.23m | no data | |
| Chief Scientific Officer | no data | no data | no data | |
| General Counsel | no data | no data | no data | |
| VP of Global Marketing & US Commercialization | 4yrs | no data | no data | |
| Executive VP of Strategic Partnerships and GM of EMEA & APAC | less than a year | no data | no data |
1.5yrs
Average Tenure
Experienced Management: BIOPOC's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Vice Chairman of the Board | 2.1yrs | DKK 715.00k | no data | |
| Independent Chairman of the Board | 2.1yrs | DKK 835.00k | no data | |
| Member of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Chairman of the Scientific Advisory Board | 9.3yrs | no data | no data | |
| Director | less than a year | no data | no data | |
| Independent Director | 3.8yrs | DKK 715.00k | 0.062% DKK 328.6k | |
| Director | 1.5yrs | DKK 292.00k | 0.039% DKK 207.0k | |
| Independent Director | 2.1yrs | DKK 275.00k | no data | |
| Vice Chairman of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.3yrs | no data | no data |
6.5yrs
Average Tenure
62yo
Average Age
Experienced Board: BIOPOC's board of directors are considered experienced (6.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/05/28 11:36 |
| End of Day Share Price | 2023/02/28 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BioPorto A/S is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Brookline Capital Markets |
| Jyoti Prakash | Edison Investment Research |
| Yi Chen | H.C. Wainwright & Co. |